The International Union of Immunological Societies (IUIS) Expert Committee on Primary Immunodeficiency met in New York City, May 31--June 1, 2011 to update the classification of human primary immunodeficiencies (PIDs). Novel developments in gene discovery and increased knowledge in the mechanisms that govern immune system development and function have resulted in the identification of several novel PIDs in the last 2 years.

The classification of primary immunodeficiencies (PIDs) provides a framework to help in the diagnostic approach to patients. As in recent classifications, eight major groups of PIDs have been included in the Tables; however the order of the Tables has been changed with Table [2](#T2){ref-type="table"} now describing the "Well-defined syndromes with immunodeficiency" (previously Table [3](#T3){ref-type="table"}) to reflect the immunological similarity between the disorders included in this Table and those in Table [1](#T1){ref-type="table"}, "Combined immunodeficiencies."

###### 

**Combined immunodeficiencies**.

  Disease                                                   Circulating T cells                                          Circulating B cells                                        Serum Ig                                            Associated features                                                                                                                                                                                              Inheritance    Genetic defect/presumed pathogenesis                                                                                                                            OMIM number
  --------------------------------------------------------- ------------------------------------------------------------ ---------------------------------------------------------- --------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------
  **1. T^−^B^+^Severe combined immunodeficiency (SCID)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  \(a\) γc deficiency                                       Markedly decreased                                           Normal or increased                                        Decreased                                           Markedly decreased NK cells; leaky cases may present with low to normal T and/or NK cells or Omenn syndrome                                                                                                      XL             Defect in γ chain of receptors for IL-2, -4, -7, -9, -15, -21                                                                                                   [300400](300400)
  \(b\) JAK3 deficiency                                     Markedly decreased                                           Normal or increased                                        Decreased                                           Markedly decreased NK cells; leaky cases may present with variable T and/or NK cells                                                                                                                             AR             Defect in Janus activating kinase 3                                                                                                                             [600173](600173)
  \(c\) IL7Rα deficiency                                    Markedly decreased                                           Normal or increased                                        Decreased                                           Normal NK cells                                                                                                                                                                                                  AR             Defect in IL-7 receptor α chain                                                                                                                                 [146661](146661)
  \(d\) CD45 deficiency\*                                   Markedly decreased                                           Normal                                                     Decreased                                           Normal γ/δ T cells                                                                                                                                                                                               AR             Defect in CD45                                                                                                                                                  [151460](151460)
  \(e\) CD3δ\*/CD3ε\*/CD3ζ\* deficiency                     Markedly decreased                                           Normal                                                     Decreased                                           Normal NK cells Noγ/δT cells                                                                                                                                                                                     AR             Defect in CD3δ, CD3ε, or CD3ζ chains of T cell antigen receptor complex                                                                                         [186790](186790), [186830](186830), [186740](186740)
  \(f\) Coronin-1A deficiency\*                             Markedly decreased                                           Normal                                                     Decreased                                           Detectable thymus                                                                                                                                                                                                AR             Defective thymic egress of T cells and defective T cell locomotion                                                                                              [605000](605000)
  **2. T^−^B^−^SCID**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  \(a\) RAG 1/2 deficiency                                  Markedly decreased                                           Markedly decreased                                         Decreased                                           May present with Omenn syndrome, expanded γ/δT cells, autoimmunity, and/or granulomas                                                                                                                            AR             Defective VDJ recombination; defect of recombinase activating gene (RAG) 1 or 2                                                                                 [601457](601457)
  \(b\) *DCLRE1C* (Artemis) deficiency                      Markedly decreased                                           Markedly decreased                                         Decreased                                           Defective VDJ recombination, radiation sensitivity; may present with Omenn syndrome                                                                                                                              AR             Defective VDJ recombination; defect in Artemis DNA recombinase repair protein                                                                                   [602450](602450)
  \(c\) DNA-PKcs deficiency\*                               Markedly decreased                                           Markedly decreased                                         Decreased                                           (Widely studied *scid* mouse defect)                                                                                                                                                                             AR             Defective VDJ recombination; defect in DNA-PKcs recombinase repair protein                                                                                      [600899](600899)
  \(d\) Reticular dysgenesis, AK2 deficiency                Markedly decreased                                           Decreased or normal                                        Decreased                                           Deficiency of T, B, and NK cells with granulocytopenia, deafness                                                                                                                                                 AR             Defective maturation of lymphoid and myeloid cells (stem cell defect) defect in mitochondrial adenylate kinase 2                                                [103020](103020)
  \(e\) Adenosine deaminase (ADA) deficiency                Absent from birth (null mutations) or progressive decrease   Absent from birth of progressive decrease                  Progressive decrease                                Decreased NK cells, often with costochondral junction flaring, neurological features, hearing impairment, lung, and liver manifestations; partial ADA deficiency may lead to delayed or milder presentation      AR             Absent ADA activity, elevated lymphotoxic metabolites (dATP, *S*-adenosylhomocysteine)                                                                          [102700](102700)
  **3. Omenn syndrome**                                     Present; restricted heterogeneity                            Normal or decreased                                        Decreased, except increased IgE                     Erythroderma, eosinophilia, adenopathies, hepatosplenomegaly                                                                                                                                                     AR             Hypomorphic mutations in RAG1/2, Artemis, IL7Rα, RMRP, ADA, DNA Ligase IV, γc, or associated with DiGeorge syndrome; some cases have no defined gene mutation   [603554](603554)
  **4. DNA ligase IV deficiency**                           Decreased                                                    Decreased                                                  Decreased                                           Microcephaly, facial dysmorphisms, radiation sensitivity; may present with Omenn syndrome or with a delayed clinical onset                                                                                       AR             DNA ligase IV defect, impaired non-homologous end joining (NHEJ)                                                                                                [601837](601837)
  **5. Cernunnos/*NHEJ1* deficiency\***                     Decreased                                                    Decreased                                                  Decreased                                           Microcephaly, *in utero* growth retardation, radiation sensitivity                                                                                                                                               AR             Cernunnos (*NHEJ1*) defect, impaired non-homologous end joining                                                                                                 [611291](611291)
  **6. CD40 ligand deficiency**                             Normal; may progressively decrease                           IgM^+^ and IgD^+^ B cells present, other isotypes absent   IgM increased or normal, other isotypes decreased   Neutropenia, thrombocytopenia; hemolytic anemia, biliary tract, and liver disease, opportunistic infections                                                                                                      XL             Defects in CD40 ligand (CD40L) cause defective isotype switching and impaired dendritic cell signaling                                                          [300386](300386)
  **7. CD40 deficiency\***                                  Normal                                                       IgM^+^ and IgD^+^ B cells present, other isotypes absent   IgM increased or normal, other isotypes decreased   Neutropenia, gastrointestinal, and liver/biliary tract disease, opportunistic infections                                                                                                                         AR             Defects in CD40 cause defective isotype switching and impaired dendritic cell signaling                                                                         [109535](109535)
  **8. Purine nucleoside phosphorylase (PNP) deficiency**   Progressive decrease                                         Normal                                                     Normal or decreased                                 Autoimmune hemolytic anemia, neurological impairment                                                                                                                                                             AR             Absent PNP,  T cell and neurologic defects from elevated toxic metabolites, especially dGTP                                                                     [164050](164050)
  **9. CD3γ deficiency\***                                  Normal, but reduced TCR expression                           Normal                                                     Normal                                                                                                                                                                                                                                                               AR             Defect in CD3 γ                                                                                                                                                 [186740](186740)
  **10. CD8 deficiency\***                                  Absent CD8, normal CD4 cells                                 Normal                                                     Normal                                                                                                                                                                                                                                                               AR             Defects of CD8 α chain                                                                                                                                          [186910](186910)
  **11. ZAP-70 deficiency**                                 Decreased CD8, normal CD4 cells                              Normal                                                     Normal                                                                                                                                                                                                                                                               AR             Defects in ZAP-70 signaling kinase                                                                                                                              [176947](176947)
  **12. Ca^++^ channel deficiency**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  \(a\) ORAI-I deficiency\*                                 Normal number, but defective TCR-mediated activation         Normal                                                     Normal                                              Autoimmunity, anhydrotic ectodermic dysplasia, non-progressive myopathy                                                                                                                                          AR             Defect in ORAI-1, a Ca^++^ release-activated channel (CRAC) modulatory component                                                                                [610277](610277)
  \(b\) STIM-1 deficiency\*                                 Normal number, but defective TCR-mediated activation         Normal                                                     Normal                                              Autoimmunity, anhydrotic ectodermic dysplasia, non-progressive myopathy                                                                                                                                          AR             Defect in STIM-1, a stromal interaction molecule Ca^++^sensor                                                                                                   [605921](605921)
  **13. MHC class I deficiency**                            Decreased CD8, normal CD4                                    Normal                                                     Normal                                              Vasculitis                                                                                                                                                                                                       AR             Mutations in *TAP*1, *TAP*2 or *TAPBP* (tapasin) genes giving MHC class I deficiency                                                                            [604571](604571)
  **14. MHC class II deficiency**                           Normal number, decreased CD4 cells                           Normal                                                     Normal or decreased                                 Failure to thrive, diarrhea, respiratory tract infections                                                                                                                                                        AR             Mutation in transcription factors for MHC class II proteins (*CIITA*, *RFX*5, *RFXAP*, *RFXANK* genes)                                                          [209920](209920)
  **15. Winged helix deficiency (nude)\***                  Markedly decreased                                           Normal                                                     Decreased                                           Alopecia, abnormal thymic epithelium, impaired T cell maturation (widely studied nude mouse defect)                                                                                                              AR             Defects in forkhead box N1 transcription factor encoded by *FOXN*1, the gene mutated in nude mice                                                               [600838](600838)
  **16. Complete DiGeorge syndrome**                        Profoundly decreased                                         Low to normal                                              Decreased                                           Lymphoproliferation (lymphadenopathy, hepatosplenomegaly), autoimmunity (may resemble IPEX syndrome), impaired T cell proliferation                                                                              AD             Deletion of chromosome 22q11.2 or in a minority of cases other chromosomal regions, including 10p; heterozygous defects in transcription factor *TBX1*          [188400](188400)
  **17. Cartilage hair hypoplasia**                         Decreased or normal; impaired lymphocyte proliferation       Normal                                                     Normal or reduced. Antibodies variably decreased    Short-limbed dwarfism with metaphyseal dysostosis, sparse hair, bone marrow failure, autoimmunity, susceptibility to lymphoma and other cancers, impaired spermatogenesis, neuronal dysplasia of the intestine   AR             Mutations in *RMRP* (RNase MRP RNA) Involved in processing of ribosomal RNA, mitochondrial DNA replication and cell cycle control                               [250250](250250)
  **18. IKAROS deficiency\***                               Normal, but impaired lymphocyte proliferation                Absent                                                     Presumably decreased                                Anemia, neutropenia, thrombocytopenia                                                                                                                                                                            AD *de novo*   Mutation in *IKAROS*, a hematopoietic specific zinc-finger protein and a central regulator of lymphoid differentiation                                          
  **19. STAT5b deficiency\***                               Modestly decreased                                           Normal                                                     Normal                                              Growth-hormone insensitive dwarfism, dysmorphic features, eczema, lymphocytic interstitial pneumonitis, autoimmunity                                                                                             AR             Defects of STAT5b, impaired development and function of γδT cells, Treg, and NK cells, impaired T cell proliferation                                            [604260](604260)
  **20. ITK deficiency\***                                  Modestly decreased                                           Normal                                                     Normal or decreased                                                                                                                                                                                                                                                  AR             Defects in *ITK*, EBV associated lymphoproliferation                                                                                                            [613011](613011)
  **21. MAGT1 deficiency\***                                Decreased CD4 cells                                          Normal                                                     Normal                                              EBV infection, lymphoma; viral infections, respiratory and GI infections                                                                                                                                         XL             Mutations in *MAGT1*, impaired Mg^++^ flux leading to impaired TCR signaling                                                                                    [300715](300715)
  **22. DOCK8 deficiency**                                  Decreased                                                    Decreased                                                  Low IgM, increased IgE                              Low NK cells, hypereosinophilia, recurrent infections; severe atopy, extensive cutaneous viral, and bacterial (staph.) infections, susceptibility to cancer                                                      AR             Defect in *DOCK*8                                                                                                                                               [243700](243700)

*XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; SCID, severe combined immune deficiency; EBV, Epstein Barr virus; Ca^++^, calcium; MHC, major histocompatibility complex*.

*\*Ten or fewer unrelated cases reported in the literature*.

*Three disorders have been added to Table [1](#T1){ref-type="table"}: DOCK8 deficiency, IKAROS deficiency, and MAGT1 deficiency*.

*Infants with SCID who have maternal T cells engraftment may have T cells that do not function normally; these cells may cause autoimmune cytopenias or graft versus host disease. Hypomorphic mutations in several of the genes that cause SCID may result in Omenn syndrome (OS), or "leaky" SCID. Both of these disorders can be associated with higher numbers of T cells and reduced rather than absent activation responses when compared with typical SCID caused by null mutations. A spectrum of clinical findings including typical SCID, OS, leaky SCID, and granulomas with T lymphopenia can be found in patients with *RAG* gene defects. RAC2 deficiency is a disorder of leukocyte motility and is reported in Table [5](#T5){ref-type="table"}; however, one patient with RAC2 deficiency was found to have absent T cell receptor excision circles (TRECs) by newborn screening, but T cell numbers and mitogen responses were not impaired. For additional syndromic conditions with T cell lymphopenia, such as DNA repair defects, cartilage hair hypoplasia, IKAROS deficiency, and NEMO syndrome, see Tables [2](#T2){ref-type="table"} and [6](#T6){ref-type="table"}; however, it should be noted that individuals with the most severe manifestations of these disorders could have clinical signs and symptoms of SCID. Severe folate deficiency (such as with malabsorption due to defects in folate carrier or transporter genes *SLC*10*A*1 or *PCFT*) and some metabolic disorders, such as methylmalonicaciduria, may present with reversible profound lymphopenia in addition to their characteristic presenting features*.

###### 

**Well-defined syndromes with immunodeficiency**.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Disease                                                                                         Circulating T cells                                               Circulating B cells                                                                   Serum Ig                                                                                              Associated features                                                                                                                                                                                                                                                                 Inheritance                  Genetic defect/presumed pathogenesis                                                                                                OMIM number
  ----------------------------------------------------------------------------------------------- ----------------------------------------------------------------- ------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ------------------
  **1. Wiskott--Aldrich syndrome (WAS)**                                                          Progressive decrease, abnormal lymphocyte responses to anti-CD3   Normal                                                                                Decreased IgM: antibody to polysaccharides particularly decreased; often increased IgA and IgE        Thrombocytopenia with small platelets; eczema; lymphoma; autoimmune disease; IgA nephropathy; bacterial and viral infections. XL thrombocytopenia is a mild form of WAS, and XL neutropenia is caused by missense mutations in the GTPase binding domain of WASP                    XL                           Mutations in *WAS*; cytoskeletal and immunologic synapse defect affecting hematopoietic stem cell derivatives                       [301000](301000)

  **2. DNA repair defects (other than those in Table [1](#T1){ref-type="table"})**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  \(a\) Ataxia--telangiectasia                                                                    Progressive decrease                                              Normal                                                                                Often decreased IgA, IgE, and IgG subclasses; increased IgM monomers; antibodies variably decreased   Ataxia; telangiectasia; pulmonary infections; lymphoreticular and other malignancies; increased alpha fetoprotein and X-ray sensitivity; chromosomal instability                                                                                                                    AR                           Mutations in *ATM*; disorder of cell cycle checkpoint and DNA double strand break repair                                            [208900](208900)

  \(b\) Ataxia--telangiectasia-like disease (ATLD)\*                                              Progressive decrease                                              Normal                                                                                Antibodies variably decreased                                                                         Moderate ataxia; pulmonary infections; severely increased radiosensitivity                                                                                                                                                                                                          AR                           Hypomorphic mutations in *MRE*11; disorder of cell cycle checkpoint and DNA double- strand break repair                             [604391](604391)

  \(c\) Nijmegen breakage syndrome                                                                Progressive decrease                                              Variably reduced                                                                      Often decreased IgA, IgE, and IgG subclasses; increased IgM; antibodies variably decreased            Microcephaly; bird like face; lymphomas; solid tumors; ionizing radiation sensitivity; chromosomal instability                                                                                                                                                                      AR                           Hypomorphic mutations in *NBS*1 (*Nibrin*); disorder of cell cycle checkpoint and DNA double-strand break repair                    [251260](251260)

  \(d\) Bloom syndrome                                                                            Normal                                                            Normal                                                                                Reduced                                                                                               Short stature; bird like face; sun-sensitive erythema; marrow failure; leukemia; lymphoma; chromosomal instability                                                                                                                                                                  AR                           Mutations in *BLM*; RecQ like helicase                                                                                              [210900](210900)

  \(e\) Immunodeficiency with centromeric instability and facial anomalies (ICF)                  Decreased or normal; Responses to PHA may be decreased            Decreased or normal                                                                   Hypogammaglobulinemia; variable antibody deficiency                                                   Facial dysmorphic features; macroglossia; bacterial/opportunistic infections; malabsorption; cytopenias; malignancies; multiradial configurations of chromosomes 1, 9, 16; no DNA breaks                                                                                            AR                           Mutations in DNA methyltransferase *DNMT*3*B* (ICF1) resulting in defective DNA methylation; or in *ZBTB*24 (ICF2)                  [242860](242860)

  \(f\) PMS2 deficiency (class switch recombination deficiency due to impaired mismatch repair)   Normal                                                            Switched and non-switched B cells are reduced                                         Low IgG and IgA, elevated IgM, abnormal antibody responses                                            Recurrent infections; café-au-lait spots; lymphoma, colorectal carcinoma, brain tumor                                                                                                                                                                                               AR                           Mutations in *PMS*2, resulting in defective CSR-induced DNA double-strand breaks in Ig switch regions                               [600259](600259)

  \(g\) Riddle syndrome\*                                                                         Normal                                                            Normal                                                                                Low IgG                                                                                               Mild motor control and learning difficulties, mild facial dysmorphism, and short stature                                                                                                                                                                                            AR                           Mutations in *RNF168*, resulting in defective DNA double-strand break repair                                                        [611943](611943)

  **3. Thymic defects**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  DiGeorge anomaly (chromosome 22q11.2 deletion syndrome)                                         Decreased or normal                                               Normal                                                                                Normal or decreased                                                                                   Hypoparathyroidism, conotruncal malformation; abnormal facies; large deletion (3 Mb) in 22q11.2 (or rarely a deletion in 10p)                                                                                                                                                       *De novo* defect or AD       Contiguous gene defect in 90% affecting thymic development; mutation in *TBX*1                                                      [188400](188400)

  **4. Immune-osseous dysplasias**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  \(a\) Cartilage hair hypoplasia                                                                 Decreased or normal; impaired lymphocyte proliferation            Normal                                                                                Normal or reduced. Antibodies variably decreased                                                      Short-limbed dwarfism with metaphyseal dysostosis, sparse hair, bone marrow failure, autoimmunity, susceptibility to lymphoma and other cancers, impaired spermatogenesis, neuronal dysplasia of the intestine                                                                      AR                           Mutations in *RMRP* (RNase MRP RNA) Involved in processing of ribosomal RNA, mitochondrial DNA replication and cell cycle control   [250250](250250)

  \(b\) Schimke syndrome                                                                          Decreased                                                         Normal                                                                                Normal                                                                                                Short stature, spondyloepiphyseal dysplasia, intrauterine growth retardation, nephropathy; bacterial, viral, fungal infections; may present as SCID; bone marrow failure                                                                                                            AR                           Mutations in *SMARCAL1*, involved in chromatin remodeling                                                                           [242900](242900)

  **5. Comel--Netherton syndrome**                                                                Normal                                                            Switched and non-switched B cells are reduced                                         Elevated IgE and IgA antibody variably decreased                                                      Congenital ichthyosis, bamboo hair, atopic diathesis, increased bacterial infections, failure to thrive                                                                                                                                                                             AR                           Mutations in *SPINK*5 resulting in lack of the serine protease inhibitor LEKTI, expressed in epithelial cells                       [256500](256500)

  **6. Hyper-IgE syndromes (HIES)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  \(a\) AD-HIES (Job syndrome)                                                                    Normal Th-17 cells decreased                                      Normal (switched and non-switched memory B cells are reduced; BAFF level increased)   Elevated IgE; specific antibody production decreased                                                  Distinctive facial features (broad nasal bridge), eczema, osteoporosis, and fractures, scoliosis, failure/delay of shedding primary teeth, hyperextensible joints, bacterial infections (skin and pulmonary abscesses, pneumatoceles) due to *Staphylococcus aureus*, candidiasis   AD, often *de novo* defect   Dominant-negative heterozygous mutations in *STAT*3                                                                                 

  \(b\) AR-HIES                                                                                                                                                                                                                                                                                                                                                 No skeletal and connective tissue abnormalities; no pneumatoceles                                                                                                                                                                                                                   AR                                                                                                                                                               

     (i) TYK2 deficiency\*                                                                        Normal, but multiple cytokine signaling defect                    Normal                                                                                (±) Elevated IgE                                                                                      Susceptibility to intracellular bacteria (mycobacteria, *Salmonella*), fungi, and viruses                                                                                                                                                                                                                        Mutation in *TYK*2                                                                                                                  [611521](611521)

     (ii) DOCK8 deficiency                                                                        Reduced                                                           Reduced                                                                               (±) Elevated IgE, low IgM                                                                             Recurrent respiratory infections; extensive cutaneous viral and staphylococcal infections, increased risk of cancer, severe atopy with anaphylaxis                                                                                                                                                               Mutation in *DOCK*8                                                                                                                 [611432](611432)

     (iii) Unknown origin                                                                         Normal                                                            Normal                                                                                Elevated IgE                                                                                          CNS hemorrhage, fungal, and viral infections                                                                                                                                                                                                                                                                     Unknown                                                                                                                             

  **7. Hepatic veno-occlusive disease with immunodeficiency (VODI)**                              Normal (decreased memory T cells)                                 Normal (decreased memory B cells)                                                     Decreased IgG, IgA, IgM absent germinal centers absent tissue plasma cells                            Hepatic veno-occlusive disease; *Pneumocystis jiroveci* pneumonia; susceptibility to CMV, candida; thrombocytopenia; hepatosplenomegaly                                                                                                                                             AR                           Mutations in *SP*110                                                                                                                [235550](235550)

  **8. Dyskeratosis congenita (DKC)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  \(a\) XL-DKC (Hoyeraal-Hreidarsson syndrome)                                                    Progressive decrease                                              Progressive decrease                                                                  Variable                                                                                              Intrauterine growth retardation, microcephaly, nail dystrophy, recurrent infections, digestive tract involvement, pancytopenia, reduced number and function of NK cells                                                                                                             XL                           Mutations in dyskerin (*DKC*1)                                                                                                      [305000](305000)

  \(b\) AR-DKC\*                                                                                  Abnormal                                                          Variable                                                                              Variable                                                                                              Pancytopenia, sparse scalp hair and eyelashes, prominent periorbital telangiectasia, and hypoplastic/dysplastic nails                                                                                                                                                               AR                           Mutation in *NOLA*2 (*NHP*2) or in *NOLA3* (*NOP10*)                                                                                [224230](224230)

  \(c\) AD-DKC                                                                                    Variable                                                          Variable                                                                              Variable                                                                                              Reticular hyperpigmentation of the skin, dystrophic nails, osteoporosis, premalignant leukokeratosis of the mouth mucosa, palmar hyperkeratosis, anemia, pancytopenia                                                                                                               AD                           Mutation in *TERC*\                                                                                                                 [127550](127550)
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Mutation in *TERT*\                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Mutation in *TINF*2                                                                                                                 

  **9. IKAROS deficiency\***                                                                      Normal, but impaired lymphocyte proliferation                     Absent                                                                                Presumably decreased                                                                                  Anemia, neutropenia, thrombocytopenia                                                                                                                                                                                                                                               AD *de novo*                 Mutation in *IKAROS*, a hematopoietic specific zinc-finger protein and a central regulator of lymphoid differentiation              
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*SCID, severe combined immune deficiency; XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; MSMD, Mendelian susceptibility of mycobacterial disease*.

*\*Ten or fewer unrelated cases reported in the literature*.

*Four disorders listed in Table [2](#T2){ref-type="table"}, complete DiGeorge anomaly, cartilage hair hypoplasia, IKAROS deficiency, and AR-HIES caused by DOCK8 deficiency, are also included in Table [1](#T1){ref-type="table"} as they are characterized by striking T and B cell abnormalities. While not all DOCK8 deficient patients have elevated serum IgE, most have recurrent viral infections and malignancies as a result of combined immunodeficiency. AR-HIES due to TYK2 deficiency is also described in Table [6](#T6){ref-type="table"}, because of its association with atypical mycobacterial disease resulting in MSMD. Because Riddle syndrome is caused by mutations in a gene involved in DNA double-strand break repair and is associated with hypogammaglobulinemia, we have added this rare syndrome to Table [2](#T2){ref-type="table"}. Chronic mucocutaneous candidiasis (CMC) has been moved to Table [6](#T6){ref-type="table"}. Autosomal dominant and autosomal recessive forms of Dyskeratosis congenita, caused by mutations of recently identified genes, have been included in this table. Finally, we added IKAROS deficiency, observed in a single case, a prematurely born infant, who died at the age of 87 days. He had absent B and NK cells and non-functional T cells, suggesting combined immunodeficiency*.

###### 

**Predominantly antibody deficiencies**.

  Disease                                                                                                    Serum Ig                                                                                           Associated features                                                                                                                                                                                                              Inheritance           Genetic defect/presumed pathogenesis                                                     OMIM number        
  ---------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------- ---------------------------------------------------------------------------------------- ------------------ --
  **1. Severe reduction in all serum immunoglobulin isotypes with profoundly decreased or absent B cells**                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  \(a\) BTK deficiency                                                                                       All isotypes decreased in majority of patients; some patients have detectable immunoglobulins      Severe bacterial infections; normal numbers of pro-B cells                                                                                                                                                                       XL                    Mutations in *BTK*, a cytoplasmic tyrosine kinase activated by crosslinking of the BCR   [300300](300300)   
  \(b\) μ Heavy chain deficiency                                                                             All isotypes decreased                                                                             Severe bacterial infections; normal numbers of pro-B cells                                                                                                                                                                       AR                    Mutations in μ heavy chain                                                               [147020](147020)   
  \(c\) λ5 deficiency\*                                                                                      All isotypes decreased                                                                             Severe bacterial infections; normal numbers of pro-B cells                                                                                                                                                                       AR                    Mutations in λ5; part of the surrogate light chain in the pre-BCR                        [146770](146770)   
  \(d\) Igα deficiency\*                                                                                     All isotypes decreased                                                                             Severe bacterial infections; normal numbers of pro-B cells                                                                                                                                                                       AR                    Mutations in Igα (*CD*79*a*); part of the pre-BCR and BCR                                [112205](112205)   
  \(e\) Igβ deficiency\*                                                                                     All isotypes decreased                                                                             Severe bacterial infections; normal numbers of pro-B cells                                                                                                                                                                       AR                    Mutations in Igβ (*CD*79*b*); part of the pre-BCR and BCR                                [147245](147245)   
  \(f\) BLNK deficiency\*                                                                                    All isotypes decreased                                                                             Severe bacterial infections; normal numbers of pro-B cells                                                                                                                                                                       AR                    Mutations in *BLNK*; a scaffold protein that binds to BTK                                [604615](604615)   
  \(g\) Thymoma with immunodeficiency                                                                        One or more isotypes may be decreased                                                              Bacterial and opportunistic infections; autoimmunity; decreased number of pro-B cells                                                                                                                                            None                  Unknown                                                                                                     
  \(h\) Myelodysplasia with hypogammaglobulinemia                                                            One or more isotypes may be decreased                                                              Infections; decreased number of pro-B cells                                                                                                                                                                                      Variable              May have monosomy 7, trisomy 8, or dyskeratosis congenita                                                   
  **2. Severe reduction in at least 2 serum immunoglobulin isotypes with normal or low number of B cells**                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  \(a\) Common variable immunodeficiency disorders                                                           Low IgG and IgA and/or IgM                                                                         Clinical phenotypes vary: most have recurrent infections, some have polyclonal lymphoproliferation, autoimmune cytopenias, and/or granulomatous disease                                                                          Variable              Unknown                                                                                                     
  \(b\) ICOS deficiency\*                                                                                    Low IgG and IgA and/or IgM                                                                                                                                                                                                                                                                                                          AR                    Mutations in *ICOS*                                                                      [604558](604558)   
  \(c\) CD19 deficiency\*                                                                                    Low IgG and IgA and/or IgM                                                                         May have glomerulonephritis                                                                                                                                                                                                      AR                    Mutations in *CD*19; transmembrane protein that amplifies signal through BCR             [107265](107265)   
  \(d\) CD81 deficiency\*                                                                                    Low IgG, low or normal IgA, and IgM                                                                May have glomerulonephritis                                                                                                                                                                                                      AR                    Mutations in *CD*81; transmembrane protein that amplifies signal through BCR             [186845](186845)   
  \(e\) CD20 deficiency\*                                                                                    Low IgG, normal or elevated IgM, and IgA                                                                                                                                                                                                                                                                                            AR                    Mutations in *CD*20                                                                      [112210](112210)   
  \(f\) TACI deficiency                                                                                      Low IgG and IgA and/or IgM                                                                         Variable clinical expression                                                                                                                                                                                                     AD or AR or complex   Mutations in *TNFRSF*13*B* (TACI)                                                        [604907](604907)   
  \(g\) BAFF receptor deficiency\*                                                                           Low IgG and IgM                                                                                    Variable clinical expression                                                                                                                                                                                                     AR                    Mutations in *TNFRSF*13*C* (BAFF-R)                                                      [606269](606269)   
  **3. Severe reduction in serum IgG and IgA with normal/elevated IgM and normal numbers of B cells**                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  \(a\) CD40L deficiency                                                                                     IgG and IgA decreased; IgM may be normal or increased; B cell numbers may be normal or increased   Opportunistic infections, neutropenia, autoimmune disease                                                                                                                                                                        XL                    Mutations in *CD*40*LG* (also called *TNFSF*5 or *CD*154)                                [300386](300386)   
  \(b\) CD40 deficiency\*                                                                                    Low IgG and IgA; normal or raised IgM                                                              Opportunistic infections, neutropenia, autoimmune disease                                                                                                                                                                        AR                    Mutations in *CD*40 (also called *TNFRSF*5)                                              [109535](109535)   
  \(c\) AID deficiency                                                                                       IgG and IgA decreased; IgM increased                                                               Enlarged lymph nodes and germinal centers                                                                                                                                                                                        AR                    Mutations in *AICDA* gene                                                                [605257](605257)   
  \(d\) UNG deficiency                                                                                       IgG and IgA decreased; IgM increased                                                               Enlarged lymph nodes and germinal centers                                                                                                                                                                                        AR                    Mutations in *UNG*                                                                       [191525](191525)   
  **4. Isotype or light chain deficiencies with normal numbers of B cells**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  \(a\) Ig heavy chain mutations and deletions                                                               One or more IgG and/or IgA subclasses as well as IgE may be absent                                 May be asymptomatic                                                                                                                                                                                                              AR                    Mutation or chromosomal deletion at 14q32                                                                   
  \(b\) κ chain deficiency\*                                                                                 All immunoglobulins have lambda light chain                                                        Asymptomatic                                                                                                                                                                                                                     AR                    Mutations in κ constant gene                                                             [147200](147200)   
  \(c\) Isolated IgG subclass deficiency                                                                     Reduction in one or more IgG subclass                                                              Usually asymptomatic; a minority may have poor antibody response to specific antigens and recurrent viral/bacterial infections                                                                                                   Variable              Unknown                                                                                                     
  \(d\) IgA with IgG subclass deficiency                                                                     Reduced IgA with decrease in one or more IgG subclass                                              Recurrent bacterial infections in majority                                                                                                                                                                                       Variable              Unknown                                                                                                     
  \(e\) Selective IgA deficiency                                                                             IgA decreased/absent                                                                               Usually asymptomatic; may have recurrent infections with poor antibody responses to carbohydrate antigens; may have allergies or autoimmune disease. A very few cases progress to CVID, others coexist with CVID in the family   Variable              Unknown                                                                                                     
  **5. Specific antibody deficiency with normal Ig concentrations and normal numbers of B cells**            Normal                                                                                             Reduced ability to make antibodies to specific antigens                                                                                                                                                                          Variable              Unknown                                                                                                     
  **6. Transient hypogammaglobulinemia of infancy with normal numbers of B cells**                           IgG and IgA decreased                                                                              Normal ability to make antibodies to vaccine antigens, usually not associated with significant infections                                                                                                                        Variable              Unknown                                                                                                     

*XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; BTK, Bruton tyrosine kinase; BLNK, B cell linker protein; AID, activation-induced cytidine deaminase; UNG, uracil-DNA glycosylase; ICOS, inducible costimulator; Ig(κ), immunoglobulin, or κ light chain type*.

*\*Ten or fewer unrelated cases reported in the literature*.

*Two new autosomal recessive disorders that might previously have been called CVID have been added to Table [3](#T3){ref-type="table"}. CD81 is normally co-expressed with CD19 on the surface of B cells. Like CD19 mutations, mutations in CD81 result in normal numbers of peripheral blood B cells, low serum IgG, and an increased incidence of glomerulonephritis. A single patient with a homozygous mutation in CD20 has been reported*.

*Common Variable Immunodeficiency Disorders (CVID) include several clinical and laboratory phenotypes that may be caused by distinct genetic and/or environmental factors. Some patients with CVID and no known genetic defect have markedly reduced numbers of B cells as well as hypogammaglobulinemia. Alterations in *TNFRSF*13*B* (*TACI*) and *TNFRSF*13*C* (*BAFF*-*R*) sequences may represent disease modifying mutations rather than disease causing mutations. CD40L and CD40 deficiency are included in Table [1](#T1){ref-type="table"} as well as this table. A small minority of patients with XLP (Table [4](#T4){ref-type="table"}), WHIM syndrome (Table [6](#T6){ref-type="table"}), ICF (Table [2](#T2){ref-type="table"}), VOD1 (Table [2](#T2){ref-type="table"}), thymoma with immunodeficiency (Good syndrome) or myelodysplasia are first seen by an immunologist because of recurrent infections, hypogammaglobulinemia, and normal or reduced numbers of B cells. Patients with GATA2 mutations (Table [5](#T5){ref-type="table"}) may have markedly reduced numbers of B cells, as well as decreased monocytes and NK cells and a predisposition to myelodysplasia but they do not have an antibody deficiency*.

###### 

**Diseases of immune dysregulation**.

  Disease                                                                                         Circulating T cells                                                                Circulating B cells                                                 Serum Ig                                           Associated features                                                                                                                                                                                                      Inheritance                         Genetic defect/presumed pathogenesis                                                                                                                                                                     OMIM number
  ----------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------- ------------------------------------------------------------------- -------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------
  **1. Immunodeficiency with hypopigmentation**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  \(a\) Chediak--Higashi syndrome                                                                 Normal                                                                             Normal                                                              Normal                                             Partial albinism, recurrent infections, late-onset primary encephalopathy, increased lymphoma risk. Neutropenia, Giant lysosomes, low NK, and CTL activities, elevation of acute phase markers                           AR                                  Mutations in *LYST*, impaired lysosomal trafficking                                                                                                                                                      [214500](214500)
  \(b\) Griscelli syndrome, type2                                                                 Normal                                                                             Normal                                                              Normal                                             Partial albinism, elevation of acute phase markers, encephalopathy in some patients. Low NK and CTL activities                                                                                                           AR                                  Mutations in *RAB*27*A* encoding a GTPase that promotes docking of secretory vesicles to the cell membrane                                                                                               [607624](607624)
  \(c\) Hermansky--Pudlak syndrome, type 2\*                                                      Normal                                                                             Normal                                                              Normal                                             Partial albinism, increased bleeding. Neutropenia, low NK, and CTL activity                                                                                                                                              AR                                  Mutations in the *AP*3*B*1 gene, encoding for the β subunit of the AP-3 complex                                                                                                                          [608233](608233)
  **2. Familial hemophagocytic lymphohistiocytosis (FHL) syndromes**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  \(a\) Perforin deficiency, FHL2                                                                 Normal                                                                             Normal                                                              Normal                                             Severe inflammation, persistent fever, cytopenias, splenomegaly. Hemophagocytosis, decreased to absent NK and CTL activities                                                                                             AR                                  Mutations in *PRF*1; perforin, a major cytolytic protein                                                                                                                                                 [603553](603553)
  \(b\) UNC13D (Munc13-4) deficiency, FHL3                                                        Normal                                                                             Normal                                                              Normal                                             Severe inflammation, persistent fever, splenomegaly, hemophagocytosis, decreased NK and CTL activities                                                                                                                   AR                                  Mutations in *UNC*13*D\** required to prime vesicles for fusion (\*as named in OMIM). Note that also in OMIM the "official" name is UNC13D deficiency with the alternative title of MUNC13D deficiency   [608898](608898)
  \(c\) Syntaxin 11 deficiency, FHL4                                                              Normal                                                                             Normal                                                              Normal                                             Severe inflammation, persistent fever, splenomegaly. Hemophagocytosis, decreased to absent NK activity                                                                                                                   AR                                  Mutations in *STX*11, required for fusion of secretory vesicles with the cell membrane and release of contents                                                                                           [603552](603552)
  \(d\) STXBP2 (Munc 18-2) deficiency, FHL5                                                       Normal                                                                             Normal                                                              Normal or low                                      Severe inflammation, fever, splenomegaly, hemophagocytosis possible bowel disease. Decreased NK and CTL activities with partial restoration after IL-2 stimulation                                                       AR                                  Mutations in *STXBP*2, required for fusion of secretory vesicles with the cell membrane and release of contents                                                                                          [613101](613101)
  **3. Lymphoproliferative syndromes**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  \(a\) SH2D1A deficiency, XLP1                                                                   Normal                                                                             Normal or reduced                                                   Normal or low                                      Clinical and immunologic abnormalities triggered by EBV infection, including hepatitis, hemophagocytic syndrome, aplastic anemia, and lymphoma. Dysgammaglobulinemia or hypogammaglobulinemia, low to absent NKT cells   XL                                  Mutations in *SH*2*D*1*A* encoding an adaptor protein regulating intracellular signals                                                                                                                   [308240](308240)
  \(b\) XIAP deficiency, XLP2                                                                     Normal                                                                             Normal or reduced                                                   Normal or low                                      Clinical and immunologic abnormalities triggered by EBV infection, including splenomegaly, hepatitis, hemophagocytic syndrome colitis                                                                                    XL                                  Mutations in *XIAP* encoding an inhibitor of apoptosis                                                                                                                                                   [300635](300635)
  **4. Syndromes with autoimmunity**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  \(a\) Autoimmune lymphoproliferative syndrome (ALPS)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
     (i) ALPS-FAS                                                                                 Increased CD4^−^ CD8^−^ double negative (DN) T cells                               Normal, but increased number of CD5^+^ B cells                      Normal or increased                                Splenomegaly, adenopathies, autoimmune cytopenias, increased lymphoma risk. Defective lymphocyte apoptosis                                                                                                               AD (AR cases are rare and severe)   Mutations in *TNFRSF*6, cell surface apoptosis receptor; in addition to germline mutations, somatic mutations cause a similar phenotype (ALPS-sFAS)                                                      [601859](601859)
     (ii) ALPS-FASLG                                                                              Increased DN T cells                                                               Normal                                                              Normal                                             Splenomegaly, adenopathies, autoimmune cytopenias, SLE defective lymphocyte apoptosis                                                                                                                                    AD AR                               Mutations in *TNFSF*6, ligand for CD95 apoptosis receptor                                                                                                                                                [134638](134638)
     (iii) ALPS-CASP10\*                                                                          Increased DN T cells                                                               Normal                                                              Normal                                             Adenopathies, splenomegaly, autoimmunity. Defective lymphocyte apoptosis                                                                                                                                                 AD                                  Mutations in *CASP*10, intracellular apoptosis pathway                                                                                                                                                   [603909](603909)
     (iv) Caspase 8 defect\*                                                                      Slightly increased DN T cells                                                      Normal                                                              Normal or decreased                                Adenopathies, splenomegaly, recurrent bacterial, and viral infections. Defective lymphocyte apoptosis and activation, hypogammaglobulinemia                                                                              AD                                  Mutations in *CASP*8, intracellular apoptosis and activation pathways                                                                                                                                    [607271](607271)
  \(v\) Activating N-RAS defect, activating K-RAS defect\*                                        Increased or normal DN T cells                                                     Elevation of CD5 B cells                                            Normal                                             Adenopathies, splenomegaly, leukemia, lymphoma. Defective lymphocyte apoptosis following IL-2 withdrawal                                                                                                                 Sporadic                            Somatic mutations in *NRAS* encoding a GTP binding protein with diverse signaling functions; activating mutations impair mitochondrial apoptosis                                                         [164790](164790)
  \(vi\) FADD deficiency\*                                                                        Increased DN T cells                                                               Normal                                                              Normal                                             Functional hyposplenism, recurrent bacterial, and viral infections, recurrent episodes of encephalopathy and liver dysfunction. Defective lymphocyte apoptosis                                                           AR                                  Mutations in *FADD* encoding an adaptor molecule interacting with FAS, and promoting apoptosis, inflammation and innate immunity                                                                         [613759](613759)
  \(b\) APECED (APS-1), autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy   Normal                                                                             Normal                                                              Normal                                             Autoimmunity, particularly of parathyroid, adrenal, and other endocrine organs, chronic candidiasis, dental enamel hypoplasia, and other abnormalities                                                                   AR                                  Mutations in *AIRE*, encoding a transcription regulator needed to establish thymic self-tolerance                                                                                                        [240300](240300)
  \(c\) IPEX, immune dysregulation, polyendocrinopathy, enteropathy (X-linked)                    Lack of (and/or impaired function of) CD4^+^ CD25^+^ FOXP3^+^ regulatory T cells   Normal                                                              Elevated IgA, IgE                                  Autoimmune enteropathy, early onset diabetes, thyroiditis hemolytic anemia, thrombocytopenia, eczema                                                                                                                     XL                                  Mutations in *FOXP*3, encoding a T cell transcription factor                                                                                                                                             [304790](304790)
  \(d\) CD25 deficiency                                                                           Normal to modestly decreased                                                       Normal                                                              Normal                                             Lymphoproliferation, autoimmunity. Impaired T cell proliferation                                                                                                                                                         AR                                  Mutations in IL-2Rα chain                                                                                                                                                                                [606367](606367)
  \(e\) ITCH deficiency\*                                                                         Not assessed (Th2 skewing in *Itch*-deficient mice)                                Not assessed (B cells are dysfunctional in *Itch*-deficient mice)   Not assessed (elevated in *Itch*-deficient mice)   Multi-organ autoimmunity, chronic lung disease, failure to thrive, developmental delay, macrocephaly                                                                                                                     AR                                  Mutations in *ITCH*, an E3 ubiquitin ligase                                                                                                                                                              [613385](613385)

*XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; DN, double negative; SL, systemic lupus erythematosus*.

*\*Ten or fewer unrelated cases reported in the literature*.

*STXBP2/Munc18-2 deficiency has been added as the cause of "FHL5," a new form of FHL. Of note, "FHL1" has not yet received a genetic/molecular identification. FADD deficiency is classified among the causes of ALPS. It should be stressed however that FADD deficiency is a more complex syndrome that encompasses hyposplenism, hence bacterial infections, as well as a brain and liver primary dysfunction. EBV-driven lymphoproliferation is also observed in ITK deficiency and in MAGT1 deficiency (Table [1](#T1){ref-type="table"})*.

Any classification of human disorders is somewhat arbitrary, and the classification of PIDs is no exception. Some disorders might well belong to more than one group. CD40 ligand deficiency, for example, is reported both in Tables [1](#T1){ref-type="table"} and [3](#T3){ref-type="table"} ("Predominantly antibody deficiencies"), to reflect the facts that failed B cell isotype switching was historically the most prominent feature of this condition (originally named Hyper-IgM syndrome) and that some patients survive into adulthood without significant opportunistic infections and do well with only immunoglobulin replacement therapy. Explanatory notes provided after each Table offer additional information (particularly where a condition appears in more than one Table) and indicate which new disorders have been added to that Table.

Although this updated classification reports on the most typical immunological findings and associated clinical and genetic features for the various PIDs, there is extensive clinical, immunological, and molecular heterogeneity that can not be easily recapitulated in a brief summary. To facilitate a more rigorous analysis of each disease, a column has been added on the right with a hyperlink to refer to its catalog number in the Online Mendelian Inheritance in Man (OMIM) publicly accessible database ([www.omim.org](www.omim.org)) of human genetic disorders. It is suggested that the reader consult this regularly updated and fully referenced resource.

The prevalence of the various PIDs varies in different countries. For this reason, in this new classification, we have elected to avoid giving a comment on the relative frequency of PID disorders. However, an asterisk has been placed in the first column, after the disease name, to identify disorders for which fewer than 10 unrelated cases have been reported in the literature. Some of these forms of PID can be considered extremely rare. Others have only recently been identified and it may be that more patients will be detected over time.

Finally, it is increasingly recognized that different mutations in the same gene may result in different phenotypes and may be associated with different patterns of inheritance. This concept of clinical, immunological, and genetic heterogeneity is assuming foremost importance. Notes in the text or in the footnotes identify such heterogeneity, when known.

The scope of the IUIS Expert Committee on Primary Immunodeficiency is to increase awareness, facilitate recognition, and promote optimal treatment for patients with Primary Immunodeficiency disorders worldwide. For this reason, in addition to periodically revising the Classification of PIDs, the Expert Committee is also actively involved in the development of diagnostic criteria and in providing, upon request, advice with regard to therapeutic guidelines.

###### 

**Congenital defects of phagocyte number, function, or both**.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Disease                                                   Affected cells                     Affected function                                                           Associated features                                                                                       Inheritance                                   Genetic defect/presumed pathogenesis                                                                                                                        OMIM number
  --------------------------------------------------------- ---------------------------------- --------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------- --------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------
  **1. Defects of neutrophil differentiation**                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  \(a\) Severe congenital neutropenia1 (ELANE deficiency)   N                                  Myeloid differentiation                                                     Subgroup with myelodysplasia                                                                              AD                                            *ELANE*: misfolded protein response                                                                                                                         [202700](202700)

  \(b\) SCN2\* (GFI 1 deficiency)                           N                                  Myeloid differentiation                                                     B/T lymphopenia                                                                                           AD                                            *GFI*1: loss of repression of ELANE                                                                                                                         [613107](613107)

  \(c\) SCN3 (Kostmann disease)                             N                                  Myeloid differentiation                                                     Cognitive and neurological defects in some patients                                                       AR                                            *HAX*1:control of apoptosis                                                                                                                                 [610738](610738)

  \(d\) SCN4 (G6PC3 deficiency)                             N + F                              Myeloid differentiation, chemotaxis, $\text{O}_{\text{2}}^{-}$ production   Structural heart defects, urogenital abnormalities, and venous angiectasis of trunks and limbs            AR                                            *G*6*PC*3: abolished enzymatic activity of glucose-6-phosphatase, aberrant glycosylation, and enhanced apoptosis of neutrophils and fibroblasts             [612541](612541)

  \(e\) Glycogen storage disease type 1b                    N + M                              Myeloid differentiation, chemotaxis, $\text{O}_{\text{2}}^{-}$ production   Fasting hypoglycemia, lactic acidosis, hyperlipidemia, hepatomegaly                                       AR                                            *G*6*PT*1: glucose-6-phosphate transporter 1                                                                                                                [232220](232220)

  \(f\) Cyclic neutropenia                                  N                                  ?                                                                           Oscillations in the number of other leukocytes and platelets                                              AD                                            *ELANE*: misfolded protein response                                                                                                                         [162800](162800)

  \(g\) X-linked neutropenia/\*myelodysplasia               N + M                              Mitosis                                                                     Monocytopenia                                                                                             XL                                            *WAS*: regulator of actin cytoskeleton (loss of autoinhibition)                                                                                             [300299](300299)

  \(h\) P14 deficiency\*                                    N + L Mel                          Endosome biogenesis                                                         Neutropenia Hypogammaglobulinemia ↓CD8 cytotoxicity partial albinism growth failure                       AR                                            *ROBLD*3: endosomal adaptor protein 14                                                                                                                      [610389](610389)

  \(i\) Barth syndrome                                      N                                  Myeloid differentiation                                                     Cardiomyopathy, growth retardation                                                                        XL                                            Tafazzin (*TAZ*) gene: abnormal lipid structure of mitochondrial membrane                                                                                   [302060](302060)

  \(j\) Cohen syndrome                                      N                                  Myeloid differentiation                                                     Retinopathy, developmental delay, facial dysmorphisms                                                     AR                                            *COH*1 gene: Pathogenesis unknown                                                                                                                           [216550](216550)

  \(k\) Poikiloderma with neutropenia                       N                                  Myeloid differentiation, $\text{O}_{\text{2}}^{-}$ production               Poikiloderma, MDS                                                                                         AR                                            *C*16*orf*57 gene: Pg unknown                                                                                                                               [604173](604173)

  **2. Defects of motility**                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  \(a\) Leukocyte adhesion deficiency type 1 (LAD1)         N + M + L + NK                     Adherence, chemotaxis, endocytosis, T/NK cytotoxicity                       Delayed cord separation, skin ulcers periodontitis leukocytosis                                           AR                                            *INTGB*2: adhesion protein (CD18)                                                                                                                           [116920](116920)

  \(b\) Leukocyte adhesion deficiency type 2 (LAD2)\*       N + M                              Rolling, chemotaxis                                                         Mild LAD type 1 features plus hh-blood group plus mental and growth retardation                           AR                                            *FUCT*1: GDP-Fucose transporter                                                                                                                             [266265](266265)

  \(c\) Leukocyte adhesion deficiency type 3 (LAD3)         N + M + L + NK                     Adherence, chemotaxis                                                       LAD type 1 plus bleeding tendency                                                                         AR                                            *KINDLIN*3: Rap1-activation of β1-3 integrins                                                                                                               [612840](612840)

  \(d\) Rac 2 deficiency\*                                  N                                  Adherence, chemotaxis $\text{O}_{\text{2}}^{-}$ production                  Poor wound healing, leukocytosis                                                                          AD                                            *RAC*2: Regulation of actin cytoskeleton                                                                                                                    [602049](602049)

  \(e\) β-actin deficiency\*                                N + M                              Motility                                                                    Mental retardation, short stature                                                                         AD                                            *ACTB*: cytoplasmic actin                                                                                                                                   [102630](102630)

  \(f\) Localized juvenile periodontitis                    N                                  Formyl peptide induced chemotaxis                                           Periodontitis only                                                                                        AR                                            *FPR*1: chemokine receptor                                                                                                                                  [136537](136537)

  \(g\) Papillon--Lefèvre syndrome                          N + M                              Chemotaxis                                                                  Periodontitis, palmoplantar hyperkeratosis in some patients                                               AR                                            *CTSC*: cathepsin C: abnormal activation of serine proteases                                                                                                [245000](245000)

  \(h\) Specific granule deficiency\*                       N                                  Chemotaxis                                                                  Neutrophils with bilobed nuclei                                                                           AR                                            *C/EBPE*: myeloid transcription factor                                                                                                                      [245480](245480)

  \(i\) Shwachman--Diamond syndrome                         N                                  Chemotaxis                                                                  Pancytopenia, exocrine pancreatic insufficiency, chondrodysplasia                                         AR                                            *SBDS*: defective ribosome synthesis                                                                                                                        [260400](260400)

  **3. Defects of respiratory burst**                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  \(a\) X-linked chronic granulomatous disease (CGD)        N + M                              Killing (faulty $\text{O}_{\text{2}}^{-}$ production)                       McLeod phenotype in patients with deletions extending into the contiguous Kell locus                      XL                                            *CYBB*: electron transport protein (gp91phox)                                                                                                               [306400](306400)

  (b-e) Autosomal CGD's                                     N + M                              Killing (faulty $\text{O}_{\text{2}}^{-}$ production)                                                                                                                                 AR                                            *CYBA*: electron transport protein (p22phox) *NCF*1: adapter protein (p47phox) *NCF*2: activating protein (p67phox) *NCF*4: activating protein (p40 phox)   [233690](233690)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               [233700](233700)[233710](233710)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               [601488](601488)

  **4. MSMD**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  \(a\) IL12 and IL23 receptor β1 chain deficiency          L + NK                             IFN-γ secretion                                                             Susceptibility to *Mycobacteria* and *Salmonella*                                                         AR                                            *IL*12*RB*1: IL12 and IL23 receptor β1 chain                                                                                                                [601604](601604)

  \(b\) IL12p40 deficiency                                  M                                  IFN-γ secretion                                                             Susceptibility to *Mycobacteria* and *Salmonella*                                                         AR                                            *IL*12*B*: subunit of IL12/IL23                                                                                                                             [161561](161561)

  \(c\) IFN-γ receptor 1 deficiency                         M + L                              IFN-γ binding and signaling                                                 Susceptibility to *Mycobacteria* and *Salmonella*                                                         AR, AD                                        *IFNGR*1: IFN-γR ligand binding chain                                                                                                                       [107470](107470)

  \(d\) IFN-γ receptor 2 deficiency                         M + L                              IFN-γsignaling                                                              Susceptibility to *Mycobacteria* and *Salmonella*                                                         AR                                            *IFNGR*2: IFN-γR accessory chain                                                                                                                            [147569](147569)

  \(e\) STAT1 deficiency (AD form)\*                        M + L                              IFN-γsignaling                                                              Susceptibility to *Mycobacteria, Salmonella*                                                              AD                                            *STAT*1                                                                                                                                                     [600555](600555)

  \(f\) Macrophage gp91 phox deficiency\*                   MΦ only                            Killing (faulty O~2-~ production)                                           Isolated susceptibility to mycobacteria                                                                   XL                                            *CYBB: electron transport protein* (*gp* 91 *phox*)                                                                                                         [306400](306400)

  \(g\) IRF8 deficiency (AD form)\*                         CD1c^+^ MDC                        Differentiation of CD1c^+^ MDC subgroup                                     Susceptibility to *Mycobacteria*                                                                          AD                                            *IRF*8: IL12 production by CD1c^+^ MDC                                                                                                                      [601565](601565)

  **5. Other defects**                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  \(a\) IRF 8-deficiency (AR form)\*                        Monocytes peripheral DC            Cytopenias                                                                  Susceptibility to *Mycobacteria*, Candida, myeloproliferation                                             AR                                            *IRF*8: IL12 production                                                                                                                                     

  \(b\) GATA2 deficiency (Mono MAC Syndrome)                Monocytes peripheral DC + NK + B   Multilineage cytopenias                                                     Susceptibility to *Mycobacteria*, Papilloma Viruses, Histoplasmosis, Alveolar proteinosis, MDS/AML/CMML   AD                                            *GATA*2: loss of stem cells                                                                                                                                 [137295](137295)

  \(c\) Pulmonary alveolar proteinosis\*                    Alveolar macrophages               GM-CSF signaling                                                            Alveolar proteinosis                                                                                      Biallelic mutations in pseudoautosomal gene   *CSF*2*RA*                                                                                                                                                  [306250](306250)
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; ACTB, actin beta; B, B-lymphocytes; CEBPE, CCAAT/enhancer-binding protein epsilon; CMML, chronic myelomonocytic leukaemia; CTSC, cathepsin C; CYBA, cytochrome b alpha subunit; CYBB, cytochrome b beta subunit; DC, dendritic cells; ELANE, elastase neutrophil-expressed; GATA2, GATA binding protein 2; IFN, interferon; IFNGR1, interferon-gamma receptor subunit 1; IFNGR2, interferon-gamma receptor subunit 2; IL12B, interleukin-12 beta subunit; IL12RB1, interleukin-12 receptor beta 1; IFR8, interferon regulatory factor 8; F, fibroblasts; FPR1, formyl peptide receptor 1; FUCT1, fucose transporter 1; GFI1, growth factor independent 1; HAX1, HLCS1-associated protein X1; ITGB2, integrin beta-2; L, lymphocytes; M, monocytes--macrophages; MDC, myeloid dendritic cells; MDS, myelodysplasia; Mel, melanocytes; MΦ, macrophages; MSMD, Mendelian susceptibility to mycobacterial disease; N, neutrophils; NCF1, neutrophil cytosolic factor 1; NCF2, neutrophil cytosolic factor 2; NCF4, neutrophil cytosolic factor 4; NK, natural killer cells; ROBLD3, roadblock domain containing 3; SBDS, Shwachman--Bodian--Diamond syndrome; STAT, signal transducer and activator of transcription*.

*\*Ten or fewer unrelated cases reported in the literature*.

*Table [5](#T5){ref-type="table"} includes seven newly described genetic defects of phagocyte number and/or function including Barth syndrome, Cohen syndrome and Poikiloderma with neutropenia. In these three clinically well-known diseases the genetic defects have been elucidated, although their molecular pathogenesis remains ill-defined. A new cause of autosomal recessive chronic granulomatous disease, namely a deficiency of the cytosolic activating protein p40 phox, has now been found in two CGD patients and is included under defects of respiratory burst. Under the heading of Mendelian susceptibility of mycobacterial disease (MSMD) two new entities were added: a) a *subgroup of X-linked gp*91 *phox deficiency* with isolated susceptibility to mycobacteria and a defect of the respiratory burst in macrophages only; b) an autosomal dominant form of IRF8 deficiency, resulting from a lack of CD1c^ +^ myeloid dendritic cells that would normally secrete IL12. The clinical phenotype of MSMD may vary, depending on the nature of the genetic defect. Finally GATA2 deficiency was recently identified as the cause of the Mono MAC syndrome, with multilineage cytopenias (of monocytes, peripheral dendritic cells, NK- and B-lymphocytes) resulting in opportunistic infections (including mycobacteria), alveolar proteinosis and malignancy*.

###### 

**Defects in innate immunity**.

  Disease                                                                          Affected cell                                                 Functional defect                                                                         Associated features                                                                                                                                        Inheritance   Genetic defect/presumed pathogenesis                                             OMIM number
  -------------------------------------------------------------------------------- ------------------------------------------------------------- ----------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------- ------------- -------------------------------------------------------------------------------- ------------------------------------------------------
  **1. Anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID)**                                                                                                                                                                                                                                                                                                                                                                                                                              
  \(a\) EDA-ID, X-linked (NEMO deficiency)                                         Lymphocytes + monocytes                                       NFκB signaling pathway                                                                    Anhidrotic ectodermal dysplasia + specific antibody deficiency (lack of Ab response to polysaccharides) + various infections (mycobacteria and pyogenes)   XL            Mutations of NEMO (*IKBKG*), a modulator of NF-κB activation                     [300291](300291), [300584](300584), [300301](300301)
  \(b\) EDA-ID, autosomal dominant\*                                               Lymphocytes + monocytes                                       NFκB signaling pathway                                                                    Anhidrotic ectodermal dysplasia + T cell defect + various infections                                                                                       AD            Gain-of-function mutation of *IKBA*, resulting in impaired activation of NF-κB   [612132](612132)
  **2. IRAK4 deficiency**                                                          Lymphocytes + monocytes                                       TIR-IRAK signaling pathway                                                                Bacterial infections (pyogenes)                                                                                                                            AR            Mutation of *IRAK*4, a component of TLR- and IL-1R-signaling pathway             [607676](607676)
  **3. MyD88 deficiency**                                                          Lymphocytes + monocytes                                       TIR-MyD88 signaling pathway                                                               Bacterial infections (pyogenes)                                                                                                                            AR            Mutation of *MYD*88, a component of the TLR and IL-1R-signaling pathway          [612260](612260)
  **4. WHIM (warts, hypogammaglobulinemia, infections, myelokathexis) syndrome**   Granulocytes + lymphocytes                                    Increased response of the CXCR4 chemokine receptor to its ligand CXCL12 (SDF-1)           Hypogammaglobulinemia, reduced B cell number, severe reduction of neutrophil count, warts/HPV infection                                                    AD            Gain-of-function mutations of *CXCR*4, the receptor for CXCL12                   [193670](193670)
  **5. Epidermodysplasia verruciformis**                                           Keratinocytes and leukocytes                                                                                                                            Human Papilloma virus (group B1) infections and cancer of the skin                                                                                         AR            Mutations of *EVER*1, *EVER*2                                                    [226400](226400)
  **6. Herpes simplex encephalitis (HSE)\***                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  \(a\) TLR3 deficiency\*                                                          Central nervous system (CNS) resident cells and fibroblasts   TLR3-dependent IFN-α, -β, and -λ induction                                                Herpes simplex virus 1 encephalitis                                                                                                                        AD            Mutations of *TLR*3                                                              [613002](613002)
  \(b\) UNC93B1 deficiency                                                         CNS resident cells and fibroblasts                            UNC-93B-dependent IFN-α, -β, and -λ induction                                             Herpes simplex virus 1 encephalitis                                                                                                                        AR            Mutations of *UNC*93*B*1                                                         [610551](610551)
  \(c\) TRAF3 deficiency                                                           CNS resident cells and fibroblasts                            TRAF3-dependent IFN-α, -β, and -λ induction                                               Herpes simplex virus 1 encephalitis                                                                                                                        AD            Mutation of *TRAF*3                                                              
  **7. Predisposition to fungal diseases\***                                       Mononuclear phagocytes                                        CARD9 signaling pathway                                                                   Invasive candidiasis and peripheral dermatophytosis                                                                                                        AR            Mutations of *CARD*9                                                             [212050](212050)
  **8. Chronic mucocutaneous candidiasis (CMC)**                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  \(a\) IL-17RA deficiency\*                                                       Epithelial cells, fibroblasts, mononuclear phagocytes         IL-17RA signaling pathway                                                                 CMC                                                                                                                                                        AR            Mutation in *IL*-17*RA*                                                          [605461](605461)
  \(b\) IL-17F deficiency\*                                                        T cells                                                       IL-17F-containing dimers                                                                  CMC                                                                                                                                                        AD            Mutation in *IL*-17*F*                                                           [606496](606496)
  \(c\) STAT1 gain-of-function                                                     T cells                                                       Gain-of-function STAT1 mutations that impair the development of IL-17-producing T cells   CMC                                                                                                                                                        AD            Mutations in *STAT*1                                                             [614162](614162)
  **9. Trypanosomiasis\***                                                                                                                       APOL-I                                                                                    Trypanosomiasis                                                                                                                                            AD            Mutation in *APOL-I*                                                             [603743](603743)

*XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; NF-κB, nuclear factor κ B; TIR, toll and interleukin 1 receptor; IFN, interferon; HP, human papilloma virus; TLR, toll-like receptor; IL: interleukin*.

*\*Ten or fewer unrelated cases reported in the literature*.

*Four new disorders have been added to Table [6](#T6){ref-type="table"}. AD TRAF3 deficiency is a new genetic etiology of HSE that has been diagnosed in a single patient. A new entry in the Table is CMC, for which three genetic etiologies have been discovered. AR IL-17RA deficiency and AD IL-17F deficiency have been found in one kindred each. Gain-of-function mutations in STAT1 have been found in over 50 patients with AD CMC. The mechanism of CMC in these patients involves impaired development of IL-17-producing T cells, due to the hyperactivity of STAT1-dependent signals*.

*XR-EDA-ID is highly heterogeneous clinically, both in terms of developmental features (some patients display osteopetrosis and lymphedema, in addition to EDA, while others do not display any developmental features) and infectious diseases (some display multiple infections, viral, fungal, and bacterial, while others display a single type of infection). The various OMIM entries correspond to these distinct clinical diseases*.

###### 

**Autoinflammatory disorders**.

  Disease                                                                                                                                  Affected cells                                            Functional defects                                                                                                                                        Associated Features                                                                                                              Inheritance   Genetic defect/presumed pathogenesis                    OMIM number
  ---------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------- ------------- ------------------------------------------------------- ------------------
  **1. Defects effecting the inflammasome**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  \(a\) Familial Mediterranean fever                                                                                                       Mature granulocytes, cytokine-activated monocytes         Decreased production of pyrin permits ASC-induced IL-1 processing and inflammation following subclinical serosal injury; macrophage apoptosis decreased   Recurrent fever, serositis and inflammation responsive to colchicine. Predisposes to vasculitis and inflammatory bowel disease   AR            Mutations of *MEFV*                                     [249100](249100)
  \(b\) Hyper IgD syndrome                                                                                                                                                                           Mevalonate kinase deficiency affecting cholesterol synthesis; pathogenesis of disease unclear                                                             Periodic fever and leukocytosis with high IgD levels                                                                             AR            Mutations of *MVK*                                      [260920](260920)
  \(c\) Muckle--Wells syndrome                                                                                                             PMNs monocytes                                            Defect in cryopyrin, involved in leukocyte apoptosis and NFkB signaling and IL-1 processing                                                               Urticaria, SNHL, amyloidosis                                                                                                     AD            Mutations of *CIAS*1(also called *PYPAF*1 *or NALP*3)   [191900](191900)
  \(d\) Familial cold autoinflammatory syndrome                                                                                            PMNs, monocytes                                           same as above                                                                                                                                             Non-pruritic urticaria, arthritis, chills, fever, and leukocytosis after cold exposure                                           AD            Mutations of *CIAS*1 Mutations of *NLRP*12              [120100](120100)
  \(e\) Neonatal onset multisystem inflammatory disease (NOMID) or chronic infantile neurologic cutaneous and articular syndrome (CINCA)   PMNs, chondrocytes                                        same as above                                                                                                                                             Neonatal onset rash, chronic meningitis, and arthropathy with fever and inflammation                                             AD            Mutations of *CIAS*1                                    [607115](607115)
  **2. Non-inflammasome-related conditions**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  \(a\) TNF receptor-associated periodic syndrome (TRAPS)                                                                                  PMNs, monocytes                                           Mutations of 55-kD TNF receptor leading to intracellular receptor retention or diminished soluble cytokine receptor available to bind TNF                 Recurrent fever, serositis, rash, and ocular or joint inflammation                                                               AD            Mutations of *TNFRSF*1*A*                               [142680](142680)
  \(b\) Early onset inflammatory bowel disease                                                                                             Monocyte/macrophage, activated T cells                    Mutation in IL-10 or IL-10 receptor leads to increase of TNFγ and other proinflammatory cytokines                                                         Early onset enterocolitis enteric fistulas, perianal abscesses, chronic folliculitis                                             AR            Mutations in *IL10, IL*10*RA*, or *IL*10*RB*            [146933](146933)
  \(c\) Pyogenic sterile arthritis, pyoderma gangrenosum, acne (PAPA) syndrome                                                             Hematopoietic tissues, upregulated in activated T cells   Disordered actin reorganization leading to compromised physiologic signaling during inflammatory response                                                 Destructive arthritis, inflammatory skin rash, myositis                                                                          AD            Mutations of *PSTPIP*1 (also called C2BP1)              [604416](604416)
  \(d\) Blau syndrome                                                                                                                      Monocytes                                                 Mutations in nucleotide binding site of CARD15, possibly disrupting interactions with lipopolysaccharides and NF-κB signaling                             Uveitis, granulomatous synovitis, camptodactyly, rash, and cranial neuropathies, 30% develop Crohn's disease                     AD            Mutations of *NOD*2 (also called CARD15)                [186580](186580)
  \(e\) Chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anemia (Majeed syndrome)\*                             Neutrophils, bone marrow cells                            Undefined                                                                                                                                                 Chronic recurrent multifocal osteomyelitis, transfusion-dependent anemia, cutaneous inflammatory disorders                       AR            Mutations of *LPIN*2                                    [609628](609628)
  \(f\) DIRA (Deficiency of the interleukin 1 receptor antagonist)\*                                                                       PMNs, monocytes                                           Mutations in the IL1 receptor antagonist allows unopposed action of interleukin 1                                                                         Neonatal onset of sterile multifocal osteomyelitis, periostitis, and pustulosis                                                  AR            Mutations of *IL*1*RN*                                  [612852](612852)

*AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; PMN, polymorphonuclear cells; ASC, apoptosis-associated speck-like protein with a caspase recruitment domain; CARD, caspase recruitment domain; CD2BP1, CD2 binding protein 1; PSTPIP1, proline/serine/threonine phosphatase-interacting protein 1; SNHL, sensorineural hearing loss; CIAS1, cold-induced autoinflammatory syndrome 1*.

*\*Ten or fewer unrelated cases reported in the literature*.

*Autoinflammatory diseases are clinical disorders marked by abnormally increased inflammation, mediated predominantly by the cells and molecules of the innate immune system, with a significant host predisposition. While the genetic defect of one of the most common autoinflammatory conditions, PFAPA, is not known, recent studies suggest that it is associated with activation of IL-1 pathway and response to IL-1 beta antagonists*.

*Muckle--Wells syndrome, familial cold autoinflammatory syndrome, and neonatal onset multisystem inflammatory disease (NOMID) which is also called chronic infantile neurologic cutaneous and articular syndrome (CINCA) are caused by similar mutations in CIAS1 mutations. The disease phenotype in any individual appears to depend on modifying effects of other genes and environmental factors*.

###### 

**Complement deficiencies**.

  Disease                                                   Functional defect                                                                                                                                                                             Associated features                                                                                                                                                    Inheritance                  Genetic defect/presumed pathogenesis                                                                                                                                                                                        OMIM number
  --------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------
  C1q deficiency                                            Absent CH50 hemolytic activity, defective MAC, faulty dissolution of immune complexes, faulty clearance of apoptotic cells                                                                    SLE-like syndrome, rheumatoid disease, infections                                                                                                                      AR                           Mutations in *C*1*QA*, *C*1*QB*, *C*1*QC*, and loss of early complement activation                                                                                                                                          [120550](120550); [601269](601269); [120575](120575)
  C1r deficiency                                            Absent CH50 hemolytic activity, defective MAC, faulty dissolution of immune complexes                                                                                                         SLE-like syndrome, rheumatoid disease, multiple autoimmune diseases, infections                                                                                        AR                           Mutations in C1r and loss of early complement activation                                                                                                                                                                    [216950](216950)
  C1s deficiency                                            Absent CH50 hemolytic activity                                                                                                                                                                SLE-like syndrome; multiple autoimmune diseases                                                                                                                        AR                           Mutations in C1s and loss of early complement activation                                                                                                                                                                    [120580](120580)
  C4 deficiency                                             Absent CH50 hemolytic activity, defective MAC, faulty dissolution of immune complexes, defective humoral immune response to carbohydrate antigens in some patients                            SLE-like syndrome, rheumatoid disease, infections *C*4*A*; homozygous; SLE, type I diabetes *C*4*B*: homozygous: bacterial meningitis                                  AR                           Mutations in *C*4*A* and *C*4*B* and loss of early complement activation                                                                                                                                                    [120810](120810); [120820](120820)
  C2 deficiency                                             Absent CH50 hemolytic activity, defective MAC, faulty dissolution of immune complexes                                                                                                         SLE-like syndrome, vasculitis, atherosclerosis, polymyositis, pyogenic infections; glomerulonephritis                                                                  AR                           Mutations in *C*2 and loss of early complement activation                                                                                                                                                                   [217000](217000)
  C3 deficiency                                             Absent CH50 and AP50 hemolytic activity, defective MAC, defective bactericidal activity, defective humoral immune response                                                                    Life threatening pyogenic infections; SLE-like disease; glomerulonephritis; atypical hemolytic--uremic syndrome; selected SNPs with age related macular degeneration   AR                           Mutations in *C*3 and loss of complement activation by classical and alternative pathways                                                                                                                                   [120700](120700)
  C5 deficiency                                             Absent CH50 and AP50 hemolytic activity, defective MAC, defective bactericidal activity                                                                                                       Neisserial infections, SLE                                                                                                                                             AR                           Mutations in *C*5α? or *C*5β? and loss of complement activation                                                                                                                                                             [120900](120900)
  C6 deficiency                                             Absent CH50 and AP50 hemolytic activity, defective MAC, defective bactericidal activity                                                                                                       Neisserial infections, SLE                                                                                                                                             AR                           Mutations in *C*6 and loss of complement activation                                                                                                                                                                         [217050](217050)
  C7 deficiency                                             Absent CH50 and AP50 hemolytic activity, defective MAC, defective bactericidal activity                                                                                                       Neisserial infections, SLE, vasculitis                                                                                                                                 AR                           Mutations in *C*7 and loss of terminal complement activation                                                                                                                                                                [217070](217070)
  C8a deficiency                                            Absent CH50 and AP50 hemolytic activity, defective MAC, defective bactericidal activity                                                                                                       Neisserial infections, SLE                                                                                                                                             AR                           Mutations in *C*8α and loss of terminal complement activation                                                                                                                                                               [120950](120950)
  C8b deficiency                                            Absent CH50 and AP50 hemolytic activity, defective MAC, defective bactericidal activity                                                                                                       Neisserial infections, SLE                                                                                                                                             AR                           Mutations in *C*8β and loss of terminal complement activation                                                                                                                                                               [120960](120960)
  C9 deficiency                                             Reduced CH50 and AP50 hemolytic activity, defective MAC, defective bactericidal activity                                                                                                      Neisserial infections, weaker association than in C5, C6, C7, or C8 deficiency                                                                                         AR                           Mutations in *C*9 and loss of terminal complement activation                                                                                                                                                                [613825](613825)
  C1 inhibitor deficiency                                   Spontaneous activation of the complement pathway with consumption of C4/C2, spontaneous activation of the contact system with generation of bradykinin from high molecular weight kininogen   Hereditary angioedema                                                                                                                                                  AD                           Mutations in *C*1 inhibitor and loss of regulation of proteolytic activities of complement C1                                                                                                                               [138470](138470)
  Factor D deficiency                                       Absent AP50 hemolytic activity                                                                                                                                                                Severe neisserial infection                                                                                                                                            AR                           Mutations in factor D (*CFD*), impairing alternative complement activation                                                                                                                                                  [134350](134350)
  Properdin deficiency                                      Absent AP50 hemolytic activity                                                                                                                                                                Severe neisserial infection                                                                                                                                            XL                           Mutations in properdin (*PFC*), impairing alternative complement activation                                                                                                                                                 [312060](312060)
  Factor I deficiency                                       Spontaneous activation of the alternative complement pathway with consumption of C3                                                                                                           Recurrent pyogenic infections, glomerulonephritis, SLE; hemolytic--uremic syndrome; selected SNPS: severe pre-eclampsia                                                AR                           Mutations in factor I(*CFI*), leading to accelerated catabolism of C3                                                                                                                                                       [610984](610984)
  Factor H deficiency                                       Spontaneous activation of the alternative complement pathway with consumption of C3                                                                                                           Hemolytic--uremic syndrome, membranoproliferative glomerulonephritis; neisserial infections; selected SNPS: severe pre-eclampsia                                       AR                           Mutations in factor H(*CFH*), leading to continuous activation of the alternative complement pathway and C3 deposition in tissues                                                                                           [609814](609814)
  MASP1 deficiency                                          Potential loss of embryonic cell migration signals                                                                                                                                            A developmental syndrome of facial dysmorphism, cleft lip, and/or palate, craniosynostosis, learning disability and genital, limb and vesicorenal anomalies            AR                           Mutations in *MASP*1 leading to impaired complement pathway through the mannan-binding lectin serine proteases                                                                                                              [600521](600521)
  3MC syndrome COLEC11 deficiency                           Potential loss of embryonic cell migration signals                                                                                                                                            A developmental syndrome of facial dysmorphism, cleft lip and/or palate, craniosynostosis, learning disability and genital, limb and vesicorenal anomalies             AR                           Gene product CL-K1, a C-type lectin that may serve as a chemoattractant                                                                                                                                                     [612502](612502)
  MASP2 deficiency\*                                        Absent hemolytic activity by the lectin pathway                                                                                                                                               Pyogenic infections; inflammatory lung disease                                                                                                                         AR                           Mutations in *MASP*2 leading to impaired complement pathway through the mannan-binding lectin serine proteases                                                                                                              [605102](605102)
  Complement receptor 3 (CR3) deficiency                    See LAD1 in Table [5](#T5){ref-type="table"}                                                                                                                                                                                                                                                                                                                         AR                           Mutations in *INTGB*2                                                                                                                                                                                                       [116920](116920)
  Membrane cofactor protein (CD46) deficiency               Inhibitor of complement alternate pathway, decreased C3b binding                                                                                                                              Glomerulonephritis, atypical hemolytic--uremic syndrome; selected SNPS: severe pre-eclampsia                                                                           AD                           Mutations in *MCP* leading to loss of the cofactor activity needed for the factor I-dependent cleavage of C3B and C4B                                                                                                       [120920](120920)
  Membrane attack complex inhibitor (CD59) deficiency       Erythrocytes highly susceptible to complement-mediated lysis                                                                                                                                  Hemolytic anemia, thrombosis                                                                                                                                           AR                           Mutations in *CD*59 leading to loss of this membrane inhibitor of the membrane attack complexes                                                                                                                             [107271](107271)
  Paroxysmal nocturnal hemoglobinuria                       Complement-mediated hemolysis                                                                                                                                                                 Recurrent hemolysis; hemoglobinuria, abdominal pain, smooth muscle dystonias, fatigue, and thrombosis                                                                  Acquired X-linked mutation   Disease results from the expansion of hematopoietic stem cells bearing mutations in *PIGA* and subsequent loss of biosynthesis of glycosylphosphatidylinositol (GPI) a moiety that attaches proteins to the cell surface.   [300818](300818)
  Immunodeficiency associated with Ficolin 3 deficiency\*   Absence of complement activation by the Ficolin 3 pathway.                                                                                                                                    Recurrent severe pyogenic infections mainly in the lungs; necrotizing enterocolitis in infancy; selective antibody defect to pneumococcal polysaccharides              AR                           Mutations in *FCN*3, leading to impaired complement deposition                                                                                                                                                              [604973](604973)

*XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; MAC, membrane attack complex; SLE, systemic lupus erythematosus; MBP, Mannose binding Protein; MASP2, MBP associated serine protease 2*.

*\*Ten or fewer unrelated cases reported in the literature*.

*New entities added to Table [8](#T8){ref-type="table"} demonstrate the important role of complement regulators in a group of well-described inflammatory disorders. In particular, we have added mutations in membrane bound as well as surface attached soluble complement regulatory proteins recognized in hemolytic--uremic syndrome, age related macular degeneration and pre-eclampsia. The connecting theme of these otherwise unrelated clinical events is excessive activation or insufficient regulation of C3; these events lead to recruitment of leukocytes and permit secretion of inflammatory and anti-angiogenic mediators that disrupt the vascular bed of the target organ. Alterations in the genes for factor B (*CFB*), factor I (*CFI*), factor H (*CFH*), and *CD*46 act as susceptibility genes rather than disease causing mutations. Population studies reveal no detectable increase in infections in MBP (also known at mannose binding lectin -- MBL) deficient adults. The 3MC syndrome, a developmental syndrome, has been variously called Carnevale, Mingarelli, Malpuech, and Michels syndrome*.
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